In the past week, SGRY stock has gone up by 7.69%, with a monthly decline of -2.19% and a quarterly plunge of -4.98%. The volatility ratio for the week is 2.65%, and the volatility levels for the last 30 days are 2.85% for Surgery Partners Inc.. The simple moving average for the past 20 days is 4.86% for SGRY’s stock, with a 5.15% simple moving average for the past 200 days.
Is It Worth Investing in Surgery Partners Inc. (NASDAQ: SGRY) Right Now?
while the 36-month beta value is 2.73.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 1 as “overweight,” 2 as “hold,” and 0 as “sell.”
The artificial intelligence (AI) revolution is already here. And it’s about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
The average price point forecasted by analysts for Surgery Partners Inc. (SGRY) is $48.90, which is $12.74 above the current market price. The public float for SGRY is 66.47M, and currently, short sellers hold a 8.96% ratio of that floaft. The average trading volume of SGRY on September 01, 2023 was 752.62K shares.
SGRY) stock’s latest price update
The stock of Surgery Partners Inc. (NASDAQ: SGRY) has increased by 0.17 when compared to last closing price of 36.20.Despite this, the company has seen a gain of 7.69% in its stock price over the last five trading days. Zacks Investment Research reported 2023-08-29 that The Zacks Medical – Services industry is growing on digital healthcare adoption. MEDP, HQY and SGRY are set to gain the most.
Analysts’ Opinion of SGRY
Many brokerage firms have already submitted their reports for SGRY stocks, with BofA Securities repeating the rating for SGRY by listing it as a “Buy.” The predicted price for SGRY in the upcoming period, according to BofA Securities is $45 based on the research report published on June 02, 2023 of the current year 2023.
SGRY Trading at -6.58% from the 50-Day Moving Average
After a stumble in the market that brought SGRY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.81% of loss for the given period.
Volatility was left at 2.85%, however, over the last 30 days, the volatility rate increased by 2.65%, as shares sank -1.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.31% lower at present.
During the last 5 trading sessions, SGRY rose by +7.69%, which changed the moving average for the period of 200-days by +21.76% in comparison to the 20-day moving average, which settled at $34.54. In addition, Surgery Partners Inc. saw 30.15% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at SGRY starting from Evans Jason Eric, who sale 1,892 shares at the price of $45.10 back on Jun 29. After this action, Evans Jason Eric now owns 424,898 shares of Surgery Partners Inc., valued at $85,329 using the latest closing price.
Owens Bradley R., the National Group President of Surgery Partners Inc., sale 7,191 shares at $36.31 during a trade that took place back on May 17, which means that Owens Bradley R. is holding 74,189 shares at $261,105 based on the most recent closing price.
Stock Fundamentals for SGRY
Current profitability levels for the company are sitting at:
- +14.09 for the present operating margin
- +18.12 for the gross margin
The net margin for Surgery Partners Inc. stands at -2.15. The total capital return value is set at 6.06, while invested capital returns managed to touch -1.20. Equity return is now at value -3.00, with -0.80 for asset returns.
Based on Surgery Partners Inc. (SGRY), the company’s capital structure generated 146.62 points at debt to equity in total, while total debt to capital is 59.45. Total debt to assets is 42.78, with long-term debt to equity ratio resting at 141.65. Finally, the long-term debt to capital ratio is 57.44.
When we switch over and look at the enterprise to sales, we see a ratio of 2.72, with the company’s debt to enterprise value settled at 0.45. The receivables turnover for the company is 5.73 and the total asset turnover is 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.87.
In a nutshell, Surgery Partners Inc. (SGRY) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.